Rocket Pharmaceuticals (NasdaqGM:RCKT) FDA announcement Transcript

Rocket Pharmaceuticals (NasdaqGM:RCKT) FDA announcement March 27, 2026 08:30 AM ET Company ParticipantsAndrew Tsai - Managing DirectorGaurav Shah - CEOJason Zemansky - VP of Equity ResearchJonathan Schwartz - Chief Science and Gene Therapy OfficerMeg Dodge - Senior VP of External AffairsMichael Ulz - Executive Director of Biotechnology Equity ResearchSarbani Chaudhuri - Chief Commercial OfficerYun Zhong - Senior VP of Biotechnology Equity ResearchConference Call ParticipantsJosh Schimmer - Biotech Equity Re ...